Arrowhead Research | ARWR - Vertriebs- Und Verwaltungskosten

Aktienkurs
72.87
Täglich Wechseln
2.34 3.32%
Monatlich
16.22%
Jährlich
419.02%
Q2 Prognose
72.33




Vertriebs- Und Verwaltungskosten Veränderung Datum
Agios Pharmaceuticals USD 38.46M 4.51M 2026-03
Alnylam Pharmaceuticals USD 282.51M 2.55M 2026-03
Anika Therapeutics USD 10.01M 14K 2025-12
Arrowhead Research USD 46.02M 8.84M 2025-12
Heron Therapeutics USD 23.74M 605K 2025-12
Incyte USD 390.41M 61.33M 2025-12
Ionis Pharmaceuticals USD 151M 21M 2026-03
Ligand Pharmaceuticals USD 28.45M 8.27M 2025-09
Merck USD 2.85B 215M 2025-12
Moderna USD 308M 40M 2025-12
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Novartis USD 3.44B 128M 2025-12
Sarepta Therapeutics USD 105.38M 28.27M 2025-12
TG Therapeutics USD 50.73M 12.64M 2025-12
Ultragenyx Pharmaceutical USD 89M 2.38M 2025-12
Vertex Pharmaceuticals USD 487M 41.9M 2025-12
Xencor USD 17.04M 70.74M 2025-12